Culmination Bio

Provider of novel therapeutics development and clinical data services

placeSt. George, Utah, United States calendar_todayFounded 2022 groups1 employees language culmination.com

Registered entities

Innovation

1 patent family — focus: Physics & computing; filing pace active. Cited 5 times.

YearFilings
20251

Investor mix

2 investors on record; lead investors include Merck Global Health Innovation Fund.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon